![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - Market Wire
[ Tue, Mar 19th 2013
] - Market Wire
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
[ Tue, Mar 19th 2013
] - WOPRAI
Chris Howerton Initiated (ACAD) at Strong Buy and Held Target at $13 on, Mar 19th, 2013
Chris Howerton of Jefferies, Initiated "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy and Held Target at $13 on, Mar 19th, 2013.
Chris has made no other calls on ACAD in the last 4 months.
There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Chris's Rating of Hold.
This is the rating of the analyst that currently disagrees with Chris
- Joseph Stringer of "Needham" Upgraded from Hold to Strong Buy on, Tuesday, November 27th, 2012
Contributing Sources
Similar Stocks and Investing Articles
[ Fri, Mar 15th 2013
] - WOPRAI
[ Tue, Mar 12th 2013
] - WOPRAI
[ Thu, Feb 14th 2013
] - WOPRAI
[ Thu, Jan 31st 2013
] - WOPRAI
[ Fri, Jul 27th 2012
] - WOPRAI
[ Thu, Jul 19th 2012
] - WOPRAI
[ Mon, Jul 16th 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Tue, Mar 27th 2012
] - WOPRAI